Chindex International (CHDX) Announces Second daVinci Sale

September 26, 2008 7:37 AM EDT

Chindex International (Nasdaq: CHDX) announced that its Medical Products division has been awarded another major contract. Chindex signed its second contract for the sale of a new daVinci S system in mainland China, demonstrating strong interest and demand for this cutting-edge, minimally-invasive surgical technology, which was approved by the State Food and Drug Administration (SFDA) of the People's Republic of China in July 2008.

The sale of the Intuitive Surgical (Nasdaq: ISRG) daVinci S robotic surgical system is to Ditan Hospital in Beijing, a 600 bed, top-level municipal hospital with a particularly strong focus on the prevention and treatment of infectious diseases and treating complications of liver disease.

Chindex is an American healthcare company that provides healthcare services and supplies medical capital equipment, instrumentation and products to the Chinese marketplace, including Hong Kong.
Subscribe to EasyStockAlerts.com Now & Get The News Before Everyone Else!


Related Categories

Corporate News

Stocks Mentioned

CHDX 5.70

-0.02 -0.35%
Volume: 60,881
Track CHDX

ISRG 126.07

-7.00 -5.26%
Volume: 1,215,776
Track ISRG


Add Your Comment